Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients

Patients were administered roxadustat orally to observe its impacts on renal anemia and sarcopenia.

Recombinant human erythropoietin was administered to patients as a control group to investigate its impacts on renal anemia and sarcopenia.